RCM
SNNA

Riverhead Capital Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Riverhead Capital Management’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,400
Closed -$3K – 1521
2018
Q4 		$3K Sell
1,400
-1,423
-50% -$12.5K ﹤0.01% 1487
2018
Q3 		$42K Sell
2,823
-292
-9% -$4.64K ﹤0.01% 1505
2018
Q2 		$47K Buy
3,115
+2,828
+985% +$48K ﹤0.01% 1469
2018
Q1 		$5K Buy
+287
New +$5.02K ﹤0.01% 1538

Other funds holding SNNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Luminus Management Houston, Texas $166M AUM 75.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return